author-photo

Kirsten van Lom

Erasmus University Rotterdam

41

Papers

1258

Citations

Citation Trend

Filter By

Papers (35) Sort By

Journal Conference Others

Molecular analysis of the erythroid phenotype of a patient with BCL11A haploinsufficiency.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (3)
The miR-200c/141-ZEB2-TGFβ axis is aberrant in human T-cell prolymphocytic leukemia.

2021 Haematologica
Show All
- Source
- Cite
- Save
Citations (1)
Archived bone marrow smears are an excellent source for NGS-based mutation detection in acute myeloid leukemia

2020 Leukemia
Show All
- Source
- Cite
- Save
Citations (1)
Persistent hematologic dysfunction after peptide receptor radionuclide therapy with 177Lu-DOTATATE

2018 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE: Incidence, Course, and Predicting Factors in Patients with Gastroenteropancreatic Neuroendocrine Tumors

2017 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (54)
Therapy-related hematological malignancies after peptide receptor radionuclide therapy with 177Lu-DOTA-Octreotate: Incidence, course & predicting factors in patients with GEP-NETs

2017 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (0)
An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation

2016 Blood
Show All
- Source
- Cite
- Save
Citations (48)
Cytokine and viral load kinetics in human herpesvirus 8-associated multicentric Castleman's disease complicated by hemophagocytic lymphohistiocytosis.

2016 International Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (6)
Leukocytosis and skin lesions: Consider malignancy; adult T-cell leukaemia/lymphoma

2016 Nederlands Tijdschrift voor Geneeskunde
Show All
- Source
- Cite
- Save
Citations (0)
Erratum to: Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib[Annals of Hematology, (2015), DOI:10.1007/s00277-014-2272-0]

2015 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (0)